Current Status of Adjuvant Therapy for Pancreatic Cancer

Por Katz, Matthew H. G., Fleming, Jason B., Lee, Jeffrey E., Pisters, Peter W. T.
Publicado em 2010

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?

Por Cooper, Amanda B., Parmar, Abhishek D., Riall, Taylor S., Hall, Bruce L., Katz, Matthew H.G., Aloia, Thomas A., Pitt, Henry A.
Publicado no J Gastrointest Surg (2014)

Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients

Por Tzeng, Ching-Wei D, Katz, Matthew H G, Lee, Jeffrey E, Fleming, Jason B, Pisters, Peter W T, Vauthey, Jean-Nicolas, Aloia, Thomas A
Publicado em 2014

Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer

Por Tran Cao, Hop S., Bouvet, Michael, Kaushal, Sharmeela, Keleman, Alex, Romney, Eric, Kim, Ginna, Fruehauf, John, Imagawa, David K., Hoffman, Robert M., Katz, Matthew H.G.
Publicado no Mol Cancer Ther (2010)

90-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality

Por Mise, Yoshihiro, Vauthey, Jean-Nicolas, Zimmitti, Giuseppe, Parker, Nathan H., Conrad, Claudius, Aloia, Thomas A., Lee, Jeffery E., Fleming, Jason B., Katz, Matthew H. G.
Publicado no Ann Surg (2015)

Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

Por Katz, Matthew H. G., Merchant, Nipun B., Brower, Steven, Branda, Megan, Posner, Mitchell C., Traverso, L. William, Abrams, Ross A., Picozzi, Vincent J., Pisters, Peter W. T.
Publicado em 2010

Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy

Por Tzeng, Ching-Wei D, Fleming, Jason B, Lee, Jeffrey E, Wang, Xuemei, Pisters, Peter W T, Vauthey, Jean-Nicolas, Varadhachary, Gauri, Wolff, Robert A, Katz, Matthew H G
Publicado em 2012

Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors

Por Landry, Christine S., Lin, Heather Y., Phan, Alexandria, Charnsangavej, Chusilp, Abdalla, Eddie K., Aloia, Thomas, Vauthey, J. Nicolas, Katz, Matthew H. G., Yao, James C., Fleming, Jason B.
Publicado em 2013

A High Lymph Node Ratio is Associated with Distant Recurrence After Surgical Resection of Ampullary Carcinoma

Por Roland, Christina L., Katz, Matthew H. G., Gonzalez, Graciela M. N., Pisters, Peter W. T., Vauthey, Jean-Nicolas, Wolff, Robert A., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Publicado no J Gastrointest Surg (2012)

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

Por Golan, Talia, Sella, Tal, O'Reilly, Eileen M, Katz, Matthew H G, Epelbaum, Ron, Kelsen, David P, Borgida, Ayelet, Maynard, Hannah, Kindler, Hedy, Friedmen, Eitan, Javle, Milind, Gallinger, Steven
Publicado no Br J Cancer (2017)

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C

Por Lambert, Laura A., Armstrong, Terri S., Lee, J. Jack, Liu, Suyu, Katz, Matthew H. G., Eng, Cathy, Wolff, Robert A., Tortorice, Melissa L., Tansey, Pier, Gonzalez-Moreno, Santiago, Lambert, Donald H., Mansfield, Paul F.
Publicado em 2009

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

Por Fogelman, David R., Holmes, Holly, Mohammed, Khalil, Katz, Matthew H. G., Prado, Carla M., Lieffers, Jessica, Garg, Naveen, Varadhachary, Gauri R., Shroff, Rachna, Overman, Michael J., Garrett, Christopher, Wolff, Robert A., Javle, Milind
Publicado no J Cachexia Sarcopenia Muscle (2014)

Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-...

Por Hiroshima, Yukihiko, Maawy, Ali, Zhang, Yong, Murakami, Takashi, Momiyama, Masashi, Mori, Ryutaro, Matsuyama, Ryusei, Katz, Matthew H. G., Fleming, Jason B., Chishima, Takashi, Tanaka, Kuniya, Ichikawa, Yasushi, Endo, Itaru, Hoffman, Robert M., Bouvet, Michael
Publicado no PLoS One (2014)

Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery

Por Yano, Shuya, Hiroshima, Yukihiko, Maawy, Ali, Kishimoto, Hiroyuki, Suetsugu, Atsushi, Miwa, Shinji, Toneri, Makoto, Yamamoto, Mako, Katz, Matthew H.G., Fleming, Jason B., Urata, Yasuo, Tazawa, Hiroshi, Kagawa, Shunsuke, Bouvet, Michael, Fujiwara, Toshiyoshi, Hoffman, Robert M.
Publicado no Cancer Gene Ther (2015)

Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

Por Roland, Christina L., Yang, Anthony D., Katz, Matthew H. G., Chatterjee, Deyali, Wang, Huamin, Lin, Heather, Vauthey, Jean N., Pisters, Peter W., Varadhachary, Gauri R., Wolff, Robert A., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Publicado no Ann Surg Oncol (2014)

The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

Por Roland, Christina L., Katz, Matthew H. G., Tzeng, Ching-Wei D., Lin, Heather, Varadhachary, Gauri R., Shroff, Rachna, Javle, Milind, Fogelman, David, Wolff, Robert A., Vauthey, Jean N., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Publicado no Ann Surg Oncol (2015)

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

Por Thomas, Ryan M., Truty, Mark J., Nogueras-Gonzalez, Graciela M., Fleming, Jason B., Vauthey, Jean-Nicolas, Pisters, Peter W. T., Lee, Jeffrey E., Rice, David C., Hofstetter, Wayne L., Wolff, Robert A., Varadhachary, Gauri R., Wang, Huamin, Katz, Matthew H. G.
Publicado em 2012

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

Por Tzeng, Ching-Wei D, Balachandran, Aparna, Ahmad, Mediha, Lee, Jeffrey E, Krishnan, Sunil, Wang, Huamin, Crane, Christopher H, Wolff, Robert A, Varadhachary, Gauri R, Pisters, Peter W T, Aloia, Thomas A, Vauthey, Jean-Nicolas, Fleming, Jason B, Katz, Matthew H G
Publicado em 2014

Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Por Cao, Hop S. Tran, Balachandran, Alpana, Wang, Huamin, Nogueras-González, Graciela M., Bailey, Christina E., Lee, Jeffrey E., Pisters, Peter W. T., Evans, Douglas B., Varadhachary, Gauri, Crane, Christopher H., Aloia, Thomas A., Vauthey, Jean-Nicolas, Fleming, Jason B., Katz, Matthew H. G.
Publicado em 2013

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Por Katz, Matthew H. G., Wang, Huamin, Fleming, Jason B., Sun, Charlotte C., Hwang, Rosa F., Wolff, Robert A., Varadhachary, Gauri, Abbruzzese, James L., Crane, Christopher H., Krishnan, Sunil, Vauthey, Jean-Nicolas, Abdalla, Eddie K., Lee, Jeffrey E., Pisters, Peter W. T., Evans, Douglas B.
Publicado em 2009